226 related articles for article (PubMed ID: 17885675)
1. Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice.
Liu CM; Yang Z; Liu CW; Wang R; Tien P; Dale R; Sun LQ
Cancer Gene Ther; 2007 Dec; 14(12):945-52. PubMed ID: 17885675
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
Reed SA; Sandesara PB; Senf SM; Judge AR
FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
[TBL] [Abstract][Full Text] [Related]
3. Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice.
Liu CM; Yang Z; Liu CW; Wang R; Tien P; Dale R; Sun LQ
Gene Ther; 2008 Feb; 15(3):155-60. PubMed ID: 18033313
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia.
Judge SM; Wu CL; Beharry AW; Roberts BM; Ferreira LF; Kandarian SC; Judge AR
BMC Cancer; 2014 Dec; 14():997. PubMed ID: 25539728
[TBL] [Abstract][Full Text] [Related]
5. Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin-induced diabetic muscle atrophy.
Hulmi JJ; Silvennoinen M; Lehti M; Kivelä R; Kainulainen H
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E307-15. PubMed ID: 22068602
[TBL] [Abstract][Full Text] [Related]
6. Signaling pathways perturbing muscle mass.
Glass DJ
Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):225-9. PubMed ID: 20397318
[TBL] [Abstract][Full Text] [Related]
7. Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism.
McFarlane C; Plummer E; Thomas M; Hennebry A; Ashby M; Ling N; Smith H; Sharma M; Kambadur R
J Cell Physiol; 2006 Nov; 209(2):501-14. PubMed ID: 16883577
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of atrogin-1/MAFbx expression by adenovirus-delivered small hairpin RNAs attenuates muscle atrophy in fasting mice.
Cong H; Sun L; Liu C; Tien P
Hum Gene Ther; 2011 Mar; 22(3):313-24. PubMed ID: 21126200
[TBL] [Abstract][Full Text] [Related]
9. Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors.
Allen DL; Unterman TG
Am J Physiol Cell Physiol; 2007 Jan; 292(1):C188-99. PubMed ID: 16885393
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of activins promotes muscle wasting and cachexia.
Chen JL; Walton KL; Winbanks CE; Murphy KT; Thomson RE; Makanji Y; Qian H; Lynch GS; Harrison CA; Gregorevic P
FASEB J; 2014 Apr; 28(4):1711-23. PubMed ID: 24378873
[TBL] [Abstract][Full Text] [Related]
11. Z-ajoene from Crushed Garlic Alleviates Cancer-Induced Skeletal Muscle Atrophy.
Lee H; Heo JW; Kim AR; Kweon M; Nam S; Lim JS; Sung MK; Kim SE; Ryu JH
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31717643
[TBL] [Abstract][Full Text] [Related]
12. Generation of reporter cell lines for factors inducing muscle wasting in cancer cachexia.
Cao Z; Jose I; Glab J; Puthalakath H; Osellame LD; Hoogenraad NJ
Anal Biochem; 2020 Oct; 606():113877. PubMed ID: 32738212
[TBL] [Abstract][Full Text] [Related]
13. Effects of the beta
Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
[TBL] [Abstract][Full Text] [Related]
14. The role of TGF-β signaling in muscle atrophy, sarcopenia and cancer cachexia.
Lan XQ; Deng CJ; Wang QQ; Zhao LM; Jiao BW; Xiang Y
Gen Comp Endocrinol; 2024 Jul; 353():114513. PubMed ID: 38604437
[TBL] [Abstract][Full Text] [Related]
15. Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression.
Durieux AC; Amirouche A; Banzet S; Koulmann N; Bonnefoy R; Pasdeloup M; Mouret C; Bigard X; Peinnequin A; Freyssenet D
Endocrinology; 2007 Jul; 148(7):3140-7. PubMed ID: 17395701
[TBL] [Abstract][Full Text] [Related]
16. Metabolic derangements of skeletal muscle from a murine model of glioma cachexia.
Cui P; Shao W; Huang C; Wu CJ; Jiang B; Lin D
Skelet Muscle; 2019 Jan; 9(1):3. PubMed ID: 30635036
[TBL] [Abstract][Full Text] [Related]
17. Myostatin gene inactivation prevents skeletal muscle wasting in cancer.
Gallot YS; Durieux AC; Castells J; Desgeorges MM; Vernus B; Plantureux L; Rémond D; Jahnke VE; Lefai E; Dardevet D; Nemoz G; Schaeffer L; Bonnieu A; Freyssenet DG
Cancer Res; 2014 Dec; 74(24):7344-56. PubMed ID: 25336187
[TBL] [Abstract][Full Text] [Related]
18. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
[TBL] [Abstract][Full Text] [Related]
19. F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities.
Sukari A; Muqbil I; Mohammad RM; Philip PA; Azmi AS
Semin Cancer Biol; 2016 Feb; 36():95-104. PubMed ID: 26804424
[TBL] [Abstract][Full Text] [Related]
20. Muscle myostatin signalling is enhanced in experimental cancer cachexia.
Costelli P; Muscaritoli M; Bonetto A; Penna F; Reffo P; Bossola M; Bonelli G; Doglietto GB; Baccino FM; Rossi Fanelli F
Eur J Clin Invest; 2008 Jul; 38(7):531-8. PubMed ID: 18578694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
